Leadership

Our proven executive team brings deep, diverse cell therapy and oncology experience and is committed to developing safe, effective, and accessible NK cell therapies for cancer. Artiva's Board of Directors and Advisors bring years of expertise to help us realize the full potential of NK cell therapies.

Fred Aslan, M.D.
Fred Aslan, M.D.
President and Chief Executive Officer
View Bio »
Jennifer Bush
Jennifer Bush
EVP, Chief Legal & People Officer
View Bio »
Michael Faerm
Michael Faerm
Chief Financial Officer
View Bio »
Tom Farrell
Tom Farrell
Founder and Chief Strategy Officer
View Bio »
Peter Flynn, Ph.D.
Peter Flynn, Ph.D.
Chief Operating Officer
View Bio »
Jason Litten, M.D.
Jason Litten, M.D.
Chief Medical Officer
View Bio »
Esther van den Boom, CPA
Esther van den Boom, CPA
Chief Accounting Officer
View Bio »
Eugene Helsel
Eugene Helsel
Vice President, Regulatory Affairs & Quality
View Bio »
John Lim, Pharm.D.
John Lim, Pharm.D.
Vice President, Clinical Operations
View Bio »
Heather Raymon, Ph.D.
Heather Raymon, Ph.D.
Vice President, Early Development and Program Management
View Bio »